FDA Grants Quick Review for Three Psychedelic Drug Trials in Major ...
1 day ago · FDA awards priority review vouchers to Compass Pathways, Usona Institute, and Transcend Therapeutics for psilocybin and methylone therapies targeting treatment-resistant depression and …
FDA grants priority vouchers to 3 psychedelic medications
2 hours ago · This follows an Executive Order issued earlier this week to speed review of psychedelic drugs, including ibogaine compounds, that have shown potential to address serious mental illnesses …
FDA grants quick review for 3 psychedelic drug trials - NBC News
7 hours ago · The Food and Drug Administration granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. NBC News' …
FDA grants priority review for 3 psychedelic drugs in line with recent ...
6 hours ago · The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder …
Psilocybin and methylone: FDA moves to fast-track review | CNN
1 day ago · Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health treatments in the United States.
FDA grants priority review to psychedelic therapies - MSN
1 day ago · The FDA has issued priority review vouchers to three companies developing psychedelic-based treatments for severe mental illnesses, after President Trump's executive order to accelerate …
FDA backs 3 psychedelic drug studies for mental illness
6 hours ago · FDA backs psychedelic drug studies by issuing priority vouchers to advance treatments for depression, PTSD, and alcohol use disorder.
FDA issues vouchers to 3 companies to help fast track review of ...
11 hours ago · The Food and Drug Administration (FDA) announced on Friday It's issuing national priority vouchers to three companies to help fast-track the review of certain psychedelic medications. …
FDA: Three psychedelic drugs to get review following Trump directive ...
10 hours ago · The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression.
Psychedelic drugs get the FDA fast-track - POLITICO
3 days ago · The list of products receiving FDA Commissioner priority review vouchers will grow this week to include three psychedelic drugs.